Genmab | GEN - Market Capitalization



Genmab reported DKK111.24B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Agios Pharmaceuticals USD 1.93B 234M Jun/2025
Almirall EUR 2.29B 195.31M Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
argenx SE EUR 28.69B 4.16B Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
Bayer EUR 25.09B 3.38B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Demant DKK 56.48B 2.04B Jun/2025
Fresenius Medical Care EUR 14.27B 870.85M Jun/2025
Galapagos EUR 1.57B 31.54M Jun/2025
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
GN Store Nord DKK 14.71B 876.01M Jun/2025
GRIFOLS EUR 6.33B 1.14B Jun/2025
Hikma Pharmaceutical GBP 4.42B 226.35M Dec/2024
Insmed USD 19.09B 5.22B Jun/2025
Merck EUR 47.83B 7.27B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025